Network origin in Warren Gumpel first degree
Entity | Entity type | Industry | |
---|---|---|---|
KetaMD, Inc.
KetaMD, Inc. Medical/Nursing ServicesHealth Services Part of Braxia Scientific Corp., KetaMD, Inc. operates as a telemedicine company. The company is based in Miami, FL. The company was founded in 2019 by Zappy Zapolin, Warren Gumpel, Leann Taylor, Kaia Roman. Warren Gumpel has been the CEO since 2019. KetaMD was acquired by Braxia Scientific Corp. on August 03, 2022 for $5.93 million.
3
| Subsidiary | Medical/Nursing Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Warren Gumpel via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CHAMPIGNON BRANDS | Biotechnology | Director/Board Member | |
Caliva, Inc.
Caliva, Inc. Agricultural Commodities/MillingProcess Industries Caliva, Inc. is a cannabis company that offers a wide range of cannabis products for delivery and in-store pickup. The company is based in San Jose, CA and was founded in 2015 by Shannon Harder Ronald. Customers can shop for edibles, flower, lotions, and tinctures from dozens of brands, including Caliva's own carefully cultivated products. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
Seedfund Capital
Seedfund Capital Investment ManagersFinance SeedFund Capital (SeedFund Capital) is a venture capital and private equity firm founded in 2022. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Pharmaceuticals: Major | Private Equity Investor | |
New College of Florida | College/University | Undergraduate Degree |
Statistics
International
United States | 5 |
Canada | 2 |
Sectoral
Health Technology | 3 |
Process Industries | 2 |
Finance | 2 |
Consumer Services | 2 |
Operational
Founder | 3 |
Corporate Officer/Principal | 2 |
Private Equity Investor | 2 |
Chairman | 1 |
Chief Operating Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Kaia Roman | 4 |
Leann Taylor | 3 |
Zappy Zapolin | 1 |
- Stock Market
- Insiders
- Warren Gumpel
- Company connections